William Blair Has Bearish Estimate for CRL Q2 Earnings
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities researchers at William Blair dropped their Q2 2025 earnings per share estimates for Charles River Laboratories International in a report released on Wednesday, February 19th. William Blair analyst M. Smock now forecasts that the medical research company will post earnings of $2.40 per share […]
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities researchers at William Blair dropped their Q2 2025 earnings per share estimates for Charles River Laboratories International in a report released on Wednesday, February 19th. William Blair analyst M. Smock now forecasts that the medical research company will post earnings of $2.40 per share […]
